Диссертация (1174297), страница 21
Текст из файла (страница 21)
Cecil, S.J. Bale, J.D. Compton, J.J. DiGiovanna, P. Fleckman, S.Lewis-Jones, G. Arseculeratne, A. Sergeant, C.S. Munro, B. El Houate, K.McElreavey, L.B. Halkjaer, H. Bisgaard, S. Mukhopadhyay, W.H. McLean// NatGenet. – 2006. – 38(4). – P. 441-6. Epub 2006 Mar 19.143.
Panelius, J. Complement system in dermatological diseases - fire under the skin. /J. Panelius, S. Meri // Front Med (Lausanne). – 2015. – 29. – 2. P. 3. doi:10.3389/fmed.2015.00003. eCollection 2015.144. Pascher, F. Sulzberger on atopic dermatitis.
/ F. Pascher // Int J Dermatol. – 1977.– 16. – P. 376-379.145. Peetermans, M. Plasminogen activation by staphylokinase enhances localspreading of S. aureus in skin infections. / M. Peetermans, T. Vanassche, L.Liesenborghs, J. Claes, G. Vande Velde, J. Kwiecinksi, T. Jin, B. De Geest, M.F.Hoylaerts, R.H. Lijnen, P. Verhamme // BMC Microbiol. – 2014. – 17. – 14. – P.310. doi: 10.1186/s12866-014-0310-7.146. Proft, T. Bacterial superantigens. / T. Proft, J.D. Fraser // Clin Exp Immunol. –2003.
– 133. – P. 299–306.147. Pulit, J. Nanosilver - making difficult decisions. / J. Pulit, M. Banach, Z.Kowalski // Ecological chemistry and engineering. – 2011. –18(2). – P. 185-196.148. Queck, S.Y. Mobile genetic element-encoded cytolysin connects virulence tomethicillin resistance in MRSA. / S.Y. Queck, B.A. Khan, R. Wang, T.H.
Bach,D. Kretschmer, L. Chen, B.N. Kreiswirth, A. Peschel, F.R. Deleo, M. Otto// PLoS Pathog. – 2009. – 5(7), e1000533. doi: 10.1371/journal.ppat.1000533.Epub 2009 Jul 31.149. Rayer, P.F.O. A Theoretical and Practical Treatise on the Diseases of the Skin/P.F.O. Rayer. – Philadelphia. – 1845.
– Carey and Hart, for G.N. Loomis.150. Rellahan, B.L. In vivo induction of anergy in peripheral V beta 8+ T cells bystaphylococcal enterotoxin B. / B.L. Rellahan, L.A. Jones, A.M. Kruisbeek, A.M.Fry, L.A. Matis // J. Exp. Med. – 1990. – 172. – P. 1091–1100.129151. Rojo, A. Staphylococcus aureus genomic pattern and atopic dermatitis: mayfactors other than superantigens be involved?/ A.
Rojo, A. Aguinaga, S.Monecke, J.R. Yuste, G. Gastaminza, A. España // Eur J Clin Microbiol InfectDis. – 2014. – 33(4). – P. 651-8.152. Saunders, S.P. Tmem79/ Matt is the matted mouse gene and is a predisposinggene for atopic dermatitis in human subjects. / S.P. Saunders, C.S.
Goh, S.J.Brown, C.N. Palmer, R.M. Porter, C. Cole, L.E. Campbell, M. Gierlinski, G.J.Barton, G. Schneider, A. Balmain, A.R. Prescott, S. Weidinger, H. Baurecht, M.Kabesch, C. Gieger, Y.A. Lee, R. Tavendale, S. Mukhopadhyay, S.W. Turner,V.B. Madhok, F.M. Sullivan, C. Relton, J. Burn, S. Meggitt, C.H. Smith, M.A.Allen, J.N. Barker, N.J.
Reynolds, H.J. Cordell, A.D. Irvine, W.H. McLean, A.Sandilands, P.G. Fallon// J Allergy Clin Immunol. – 2013. – 132. – P. 1121- 9.153. Schlievert, P.M. Secreted virulence factor comparison between methicillinresistant and methicillin-sensitive Staphylococcus aureus, and its relevance toatopic dermatitis. / P.M. Schlievert, K.L. Strandberg, Y.C. Lin, M.L. Peterson,D.Y. Leung // J. Allergy Clin. Immunol. – 2010.
– 125. – P. 39–49.154. Schlievert, P.M. Superantigen Profile of Staphylococcus aureus Isolates fromPatients with Steroid Resistant Atopic Dermatitis. / P.M. Schlievert, L. Case, K.L.Strandberg, B. Abrams, D.Y. Leung // Clinical Infectious Diseases. – 2008. –46(10). – P.
1562-1567.155. Schmid-Ott, G. Levels of circulating CD8(+) T lymphocytes, natural killer cells,and eosinophils increase upon acute psychosocial stress in patients with atopicdermatitis. / G. Schmid-Ott, B. Jaeger, C. Adamek, H. Koch, F. Lamprecht, A.Kapp, T. Werfel // J Allergy Clin Immunol. – 2001. – 107. P. 171-7.156. Simons, F.E. Histamine and H1-antihistamines: celebrating a century of progress./ F.E. Simons, K.J. Simons // J. Allergy Clin.
Immunol. – 2011. – 128(6). – P.1139–1150.157. Simpson, E. Two Phase 3 Trials of Dupilumab versus Placebo in AtopicDermatitis. / E.L. Simpson, T. Bieber, E. Guttman - Yassky, L.A. Beck, A.Blauvelt, M.J. Cork, J.I. Silverberg, M. Deleuran, Y. Kataoka, J.P. Lacour, K.130Kingo, M. Worm, Y. Poulin, A. Wollenberg, Y. Soo, N.M.
Graham, G. Pirozzi,B. Akinlade, H. Staudinger, V. Mastey, L. Eckert, A. Gadkari, N. Stahl, G.D.Yancopoulos, M. Ardeleanu // N Engl J Med. – 2016. – 375(24). – P. 2335-2348.Epub 2016 Sep 30.158. Skov, L. Application of staphylococcal enterotoxin B on normal and atopic skininduces up-regulation of T cells by a superantigen-mediated mechanism. / L.Skov, J.V. Olsen, R. Giorno, P.M. Schlievert, O. Baadsgaard, D.Y. Leung // J.Allergy Clin. Immunol.
– 2000. – 105. – P. 820–826.159. Stadler, J.F. Severity Scoring of Atopic Dermatitis: the SCORAD Index.Consensus Report of the European Task Force on Atopic Dermatitis /J.F. Stadler,A. Taieb, D.J. Atherton et al. //Dermatology. – 1993. – Vol.186, N1. – P.23-31160. Steed, L.L. Reduction of nasal Staphylococcus aureus carriage in health careprofessionals by treatment with a nonantibiotic, alcohol-based nasal antiseptic.
/L.L Steed, J. Costello, S. Lohia, T. Jones, E. W. Spannhake, S. Nguyen // Am JInfect Control. – 2014. – ;42(8). – P. 841-6. doi: 10.1016/j.ajic.2014.04.008.Epub 2014 Jun 2.161. Stelwagon, L. Prurigo Infantum; Psoriasis-Eczema; Primary Pigmented Sarcomaof the Skin; Xeroderma Pigmentosum; Dermatitis Herpetiformis. On the natureand treatment of eczema. / L. Stelwagon// The American Journal of the MedicalSciences.
– 1891. – 101. – P. 95 - 96.162. Strachan, D. Hay fever, hygiene, and household size. / D. Strachan// BMJ. –1989. – 299. – P. 1249-1260.163. Sullivan, M. Current and emerging concepts in atopic dermatitis pathogenesis./M. Sullivan, N.B. Silverberg // Clin Dermatol. – 2017. – 35(4). – P. 349-353.doi: 10.1016/j.clindermatol.2017.03.006. Epub 2017 Mar 23.164. Taïeb, A. Handbook of Atopic Eczema / A. Taïeb, D.
Wallach, G. Tiles. – 2006.– Springer. – Berlin, Germany.165. Taylan, F. Whole-exome sequencing of Ethiopian patients with ichthyosisvulgaris and atopic dermatitis. / F. Taylan, D. Nilsson, S. Asad, A. Lieden, C.F.131Wahlgren, M.C. Winge, K.D. Bilcha, M. Nordenskjöld, M. Bradley // J All andClin Immunol. – 2015. – 136(2). – P. 507- 509e19.166. Thomas, D. Diversity in Staphylococcus aureus enterotoxins. / D. Thomas, S.Chou, O.
Dauwalder, G. Lina // Chem Immunol Allergy. – 2007. – 93. – P. 24–41.167. Thomas, D. Staphylococcus aureus superantigens elicit redundant and extensivehuman Vbeta patterns / D. Thomas, O. Dauwalder, V. Brun, C. Badiou, T.Ferry, J. Etienne, F. Vandenesch, G. Lina // Infect Immun. – 2009. – 77(5). – P.2043-50.168. Todd, J.
Toxic-shock syndrome associated with phage-group 1 staphylococci. / J.Todd, M. Fishaut, F. Kapral, T. Welch // Lancet. – 1978. – 2. – P. 1116–8.169. Toyoda, M. Nerve growth factor and substance P are useful plasma markers ofdisease activity in atopic dermatitis. / M.
Toyoda, M. Nakamura, T. Makino, T.Hino, M. Kagoura, M. Morohashi // Br J Dermatol. – 2002. – 147. – P. 71-9.170. Trautmann, A. T cell-mediated fas-induced eratinocytes apoptosis plays a keypathogenic role in eczematous dermatitis. / A. Trautmann, M. Akdis, D.Kleemann, F. Altznauer, H.U Simon, T. Graeve, M. Noll, E.B. Bröcker, K.Blaser, C.A.
Akdis // J Clin Invest. – 2000. – 106. – P. 25-35.171. Tsakok, T. Methotrexate vs. ciclosporin in the treatment of severe atopicdermatitis in children: a critical appraisal / T. Tsakok, C. Flohr // Br J Dermatol. –2014. – 170(3). – P. 496–498.172. Unknown. Besnier's Prurigo. / Unknown/ The Lancet. – 1952. – 259. – P. 406407.173. van Belkum, A. Reclassification of Staphylococcus aureus Nasal Carriage Types./ A. van Belkum, N.J. Verkaik, C.P.
de Vogel, H.A. Boelens, J. Verveer, J.L.Nouwen, H.A. Verbrugh, H.F. Wertheim // J. Infect. Dis. – 2009. – 199. – P.1820–1826.174. van Bijnen, E.M. Primary care treatment guidelines for skin infections in Europe:congruence with antimicrobial resistance found in commensal Staphylococcusaureus in the community. / E.M. van Bijnen, W.J. Paget, C.D. den Heijer, E.E.132Stobberingh, C.A. Bruggeman, F.G. Schellevis // BMC Fam Pract. – 2014. – 15.– 175. doi: 10.1186/s12875-014-0175-8.175. Van Hasselt, P. Colloidal silver as an antimicrobial agent: fact or fiction? / P. VanHasselt, B.A. Gashe, J.
Ahmad // J Wound Care. – 2004. – 13(4). – P. 154-5.176. Van Wamel, W.J.B. The innate immune modulators staphylococcal complementinhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are locatedon β-hemolysin-converting bacteriophages. / W.J.B. Van Wamel, S.H.M.Rooijakkers, M. Ruyken, K.P.M.
van Kessel, J.A.G. van Strijp. Journal ofBacteriology. – 2006. – 188(4). – P. 1310-1315. doi:10.1128/JB.188.4.13101315.2006.177. Vasilopoulos, Y. The 3-UTR AACCins5874 in the stratum corneumchymotryptic enzyme gene (SCCE/KLK7), associated with atopic dermatitis;causes an increased mRNA expression without altering its stability. / Y.Vasilopoulos, N. Sharaf, F.di Giovine, M. Simon, M.J. Cork, G.W.
Duff, R. TaziAhnini // J Dermatol Sci. – 2011. – 61. – P. 131-3.178. Ventura, C.L. Identification of a novel Staphylococcus aureus two-componentleukotoxin using cell surface proteomics. / C.L. Ventura, N. Malachowa, C.H.Hammer, G.A. Nardone, M.A. Robinson, S.D. Kobayashi, F.R. DeLeo // PLoSONE. – 2010. – 5. – e11634.179.
Verdon, J. Delta-hemolysin, an update on a membrane-interacting peptide. / J.Verdon, N. Girardin, C. Lacombe, J.M. Berjeaud, Y. Hechard // Peptides. – 2009.– 30. – P. 817–823.180. Wallach, D. Histoire de la dermatite atopique. / D. Wallach, G. Tilles, A. Taieb.– 2004. – Masson. – Paris.181. Watanabe, H.
Emergence and spread of low-level mupirocin resistance inmethicillin-resistant Staphylococcus aureus isolated from a community hospitalin Japan. / H. Watanabe, H. Masaki, N. Asoh, K. Watanabe, K. Oishi, A.Furumoto, S. Kobayashi, A. Sato, T.
Nagatake // J Hosp Infect. – 2001. – 47(4). –P. 294-300.133182. Wen, H.J. Predicting risk for early infantile atopic dermatitis by hereditary andenvironmental factors / H.J. Wen, P.C. Chen, T.L. Chiang, S.J. Lin, Y.L. Chuang,Y.L. Guo // Br J Dermatol. – 2009. – 5(161). – P.
1166-72.183. Wertheim, H.F. The role of nasal carriage in Staphylococcus aureus infections. /H.F. Wertheim, D.C. Melles, M.C. Vos, W. van Leeuwen, A. van Belkum, H.A.Verbrugh, J.L. Nouwen // Lancet Infect Dis. – 2005. – 5. – P. 751–762.184. Williams, H. C. Epidemiology of human atopic dermatitis — seven areas ofnotable progress and seven areas of notable ignorance. /H.C. Williams // VetDermatol. – 2013. – 24(1).
– P. 3–9.185. Williamson, D. A. High usage of topical fusidic acid and rapid clonal expansionof fusidic acid-resistant Staphylococcus aureus: a cautionary tale. /D.A.Williamson, S. Monecke, H. Heffernan, S.R. Ritchie, S.A. Roberts, A.Upton, M.G. Thomas, J.D. Fraser // Clin Infect Dis. – 2014. – 59(10). – P. 14514. doi: 10.1093/cid/ciu658.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
